Tag: HIV

The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS).

India Supplying the World with Two-Thirds of AIDS Treatment Drugs

india pharma
Taking a lead in the global fight against AIDS, India is supplying the world with two-thirds of the drugs to treat those infected with HIV, according to Indian diplomat Paulomi Tripathi.  "These affo...

Gilead to Donate Truvada To the U.S. Centers for Disease Control and Prevention

Gilead Sciences, Inc. (Nasdaq: GILD) announced that it will donate Truvada for PrEP® (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg tablets) to the U.S. Centers for Disease Control and...

Russian Companies to Scale Up Production of Innovative HIV Drug

Pharmstandard, the leader of the Russian pharmaceutical market, and ChemRar Group, the leading developer of medical products, have combined their efforts to scale up the production of Elpida®, a Russi...

World’s First Point-of-Care HIV Test Received WHO PQ Approval

Abbott announced that m-PIMA™ HIV-1/2 VL, the world's first point-of-care viral load diagnostic test, has received the World Health Organization's Prequalification approval (WHO PQ). The test received...

Servier Launched the Production of a Drug for the Treatment of HIV infection

On April 25, the first production line of an innovative drug for the treatment of HIV infection in Russia was launched at the Servier pharmaceutical plant in Moscow. Alexander Prokhorov, Head of th...

Tablets for HIV-1 Infection Treatment Got FDA Approval

ViiV Healthcare announced that the US Food and Drug Administration (FDA) approved Dovato, a complete, once-daily, single-tablet regimen of dolutegravir (DTG) 50 mg and lamivudine (3TC) 300 mg for the ...

AbCellera to Initiate Global Health Research

AbCellera announced a two-year agreement with the Bill & Melinda Gates Foundation to help accelerate global health research. The funding, totaling $4.8 M, will support a series of scientific colla...

Monthly and Daily Treatment of HIV-1 Showed Same Efficacy

Johnson & Johnson’s subsidiary Janssen Pharmaceuticals and ViiV Healthcare have revealed 48 week data from two pivotal Phase III trials showing injections of their long-acting, monthly combination...

Second Patient in Remission from HIV after Stem Cell Transplant

An HIV positive man in London has become the second person ever to be declared in remission from the virus. The case is a proof of the concept that scientists will one day be able to end AIDS, his ...

New Vaccine Approach for HIV

Leti, a research institute of CEA Tech, in collaboration with CEA's Fundamental Research Division, has developed a new vaccine approach for HIV based on engineered lipid nanoparticles that deliver p24...

Combined Treatment for HIV and Visceral Leishmaniasis Coinfection

A combination of AmBisome monotherapy and miltefosine could be beneficial when treating a coinfection of HIV and visceral leishmaniasis. In at least 35 countries, in four different continents, coin...

Global Fund Plans to Rise $14bn for AIDS, TB, Malaria Fight

An international health fund that finances the fight against acquired immune deficiency syndrome (AIDS), tuberculosis (TB) and malaria has announced a $14bn fundraising target for the next three years...

Genetic Immunity presented its immunotherapy platform in Russia

clinical trials
Genetic Immunity announced that it was invited to present at the first Russian-Chinese HIV Congress in Moscow (Russia).

MSD receives EU approval for two HIV medicines

hiv
MSD (known as Merck in the USA and Canada) announced that the European Commission has approved DELSTRIGO and PIFELTRO for the treatment of HIV-1 infection.

EECA states join their efforts in fight against communicable diseases

microscope
Minsk is hosting the Eastern Europe and Central Asia (EECA) Regional Consultation on Expanding Access to Affordable and Quality Assured Antiretroviral and Antituberculosis Medicines.

Belarus is hosting the second EECA consultation on ARV and TB drugs

belarus
Belarus' Deputy Premier, spoke at the Eastern Europe and Central Asia Regional Consultation on Expanding Access to Affordable and Quality Assured ARV and TB Medicines in Minsk.